In our prior work in RCC, we observed CD73 expression in 19% of primary tumors and that expression was significantly more common in metastatic tumor samples (67%).17 CD73 expression in the primary tumor was associated with a trend towards higher nuclear grade and numerically worse 5-year OS. This evidence concerns the gene NT5E and renal cell carcinoma.